• Partnerships,

Health Innovation Fair La Tribune: iaelyon partner of the 2022 edition

Published on October 11, 2022 Updated on October 19, 2022
Forum Santé Innovation La Tribune 2022
Forum Santé Innovation La Tribune 2022

While the keys of tomorrow’s medicine are biotechnological and numerical, the project France 2023 launched by Emmanuel Macron will have to be well equipped to create tomorrow’s medicine and to make them affordable to all. But “France 2030” only makes sense with more physicians and better hospitals. Many stakes which are investigated during the 3rd Health Innovation Fair, organized by La Tribune with the support of iaelyon.

Program and free registration
The Health Innovation Fair organized by La Tribune is a go-to economic event in Health

2 years after the health crisis, French people are starting to understand the extent of the damage: we must rebuild our health system compromised by bureaucracy and give the pharmaceutical companies the financial support they need.
  • How to leave our bad posture on medicine development which does not encourage big pharma to invest in France?
  • Will the great leaders of Europe finally give the means to outline a true Union in terms of Health?
  • How can a return to health excellence be achieved in the AURA region, a French center of excellence?
  • And how can we re-establish equal access to care at the regional level?
 

iaelyon, programs in health management and marketing since 1991

iaelyon developed a portfolio for students and practitioners, managers or scientists.
 
  • The M.Sc. Management in Pharmaceutical Companies and Medical Technologies , created in 1991 aims to provide a double technical and managerial skill, adapted to the increasing quality requirements, regulations and technological developments in the pharmaceutical sector. It educates skillfull and agile executives, mastering all the tools and methods specific to a dynamic, internationalized and innovative sector covering gene therapy, oncology, diagnosis, information and communication technologies.
 
  • The MSc. Quality Management in Pharmaceutical and Biomedical Industries, created in 2019 in partnership with IFTLM -UCLy. This Master is designed for students with 3 or 4 years in higher education in Biology, Pharmacy and Life Sciences. It enables future healthcare professionals to benefit from genuine scientific, technological, and regulatory expertise by developing a solid foundation of skills in management, biomedical diagnosis, as well as in the implementation or accreditation process.